Table 2.

Online information for AIBD patients and health care professionals during the COVID-19 pandemic

Organization/source	Patient information available online	Subject of information
EADV Task Force on AIBD	https://www.eadv.org/covid-19/task-force	PPM, therapy
ERN	https://ern-skin.eu/covid-19/	PPM, therapy
IPPF	http://www.pemphigus.org/information-for-pemphigus-and-pemphigoid-patients-related-to-coronavirus-disease-covid-19/	PPM, therapy
NICE guideline	https://www.nice.org.uk/guidance/ng169	Biologic/immunomodulatory therapy
BAD	http://www.bad.org.uk/healthcare-professionals/covid-19	Biologic/immunomodulatory therapy
AAD	https://www.aad.org/member/practice/coronavirus/clinical-guidance/biologics	Biologic therapy
WHO	www.who.int	General situation and precautions
CDC	www.cdc.gov	General situation and precautions

AAD, American Academy of Dermatology; AIBD, autoimmune bullous dermatoses; BAD, British Association of Dermatologists; CDC, Centers for Disease Control and Prevention; EADV, European Academy of Dermatology and Venereology; ERN, European Reference Networks for rare diseases; IPPF, International Pemphigus & Pemphigoid Foundation; NICE, National Institute for Health and Care Excellence; PPM, personal protective measures; WHO, World Health Organization.